37.15
price up icon0.27%   0.10
after-market After Hours: 37.57 0.42 +1.13%
loading
Newamsterdam Pharma Company Nv stock is traded at $37.15, with a volume of 2.79M. It is up +0.27% in the last 24 hours and up +53.58% over the past month. NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$37.05
Open:
$36.76
24h Volume:
2.79M
Relative Volume:
3.04
Market Cap:
$4.18B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-17.28
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
+14.38%
1M Performance:
+53.58%
6M Performance:
+145.70%
1Y Performance:
+104.23%
1-Day Range:
Value
$36.74
$39.76
1-Week Range:
Value
$31.49
$39.76
52-Week Range:
Value
$14.06
$39.76

Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile

Name
Name
Newamsterdam Pharma Company Nv
Name
Phone
35 206 2971
Name
Address
GOOIMEER 2-35, NARRDEN
Name
Employee
77
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NAMS's Discussions on Twitter

Compare NAMS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NAMS
Newamsterdam Pharma Company Nv
37.15 4.17B 14.09M -176.94M -141.24M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-25-25 Initiated Wells Fargo Overweight
Jul-17-25 Initiated Goldman Neutral
Jun-17-25 Initiated Citigroup Buy
Jun-10-25 Initiated Stifel Buy
Jun-04-25 Initiated Cantor Fitzgerald Overweight
Dec-30-24 Initiated H.C. Wainwright Buy
May-15-24 Initiated TD Cowen Buy
Mar-14-24 Initiated Scotiabank Sector Outperform
Jan-18-24 Initiated Guggenheim Buy
Jan-16-24 Initiated Piper Sandler Overweight
Oct-30-23 Initiated RBC Capital Mkts Outperform
View All

Newamsterdam Pharma Company Nv Stock (NAMS) Latest News

pulisher
11:14 AM

Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockMarket Performance Summary & Accurate Trade Setup Notifications - newser.com

11:14 AM
pulisher
10:39 AM

NewAmsterdam Pharma Company N.V. recovery potential after sell offM&A Rumor & Stock Portfolio Risk Control - newser.com

10:39 AM
pulisher
09:49 AM

How to track smart money flows in NewAmsterdam Pharma Company N.V. Equity WarrantSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com

09:49 AM
pulisher
09:07 AM

Is it too late to sell NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & High Conviction Buy Zone Picks - newser.com

09:07 AM
pulisher
08:34 AM

Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V.Recession Risk & Fast Exit/Entry Strategy Plans - newser.com

08:34 AM
pulisher
08:22 AM

Published on: 2025-10-13 07:22:45 - newser.com

08:22 AM
pulisher
05:16 AM

Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com

05:16 AM
pulisher
Oct 12, 2025

Published on: 2025-10-12 22:17:07 - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Is NewAmsterdam Pharma Company NV a good long term investment - earlytimes.in

Oct 12, 2025
pulisher
Oct 11, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Hits New 12-Month HighHere's Why - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

NewAmsterdam Pharma (NAMS) Stock Soars on Cholesterol Drug Breakthrough – What Investors Should Know - ts2.tech

Oct 11, 2025
pulisher
Oct 10, 2025

NAMS Stock Surge: What Lies Ahead? - timothysykes.com

Oct 10, 2025
pulisher
Oct 10, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Why NewAmsterdam Pharma (NAMS) Is Up 7.5% After Late-Stage Obicetrapib Trial Optimism - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant stock trend forecastMarket Sentiment Review & Weekly High Conviction Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:23:44 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V. Equity WarrantEarnings Beat & Reliable Price Breakout Signals - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is this a good reentry point in NewAmsterdam Pharma Company N.V.Weekly Stock Analysis & Smart Investment Allocation Insights - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Custom watchlist performance reports with NewAmsterdam Pharma Company N.V.Weekly Market Report & Daily Technical Forecast Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

NewAmsterdam Pharma Company N.V. stock momentum explainedTrend Reversal & AI Enhanced Execution Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com Nigeria

Oct 09, 2025
pulisher
Oct 08, 2025

Knights of Columbus Asset Advisors LLC Invests $595,000 in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

NewAmsterdam Pharma Hits New 52-Week High of $34.62 - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

NewAmsterdam Pharma Company N.V. (NAMS) Soars 5.9%: Is Further Upside Left in the Stock? - Nasdaq

Oct 07, 2025
pulisher
Oct 07, 2025

Newamsterdam Pharma stock hits 52-week high at 31.96 USD By Investing.com - Investing.com Canada

Oct 07, 2025
pulisher
Oct 06, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Stock Price Up 8.8%Here's Why - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

NewAmsterdam Pharma Co. Hits New 52-Week High of USD 31.81 - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

Newamsterdam Pharma stock hits 52-week high at 31.96 USD - Investing.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Institutional scanner results for NewAmsterdam Pharma Company N.V.Portfolio Risk Report & Entry Point Confirmation Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How NewAmsterdam Pharma Company N.V. stock performs in weak economyWeekly Stock Summary & Smart Money Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 03:30:23 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

NewAmsterdam Pharma Company N.V. Equity Warrant stock retracement – recovery analysisStock Surge & Real-Time Market Sentiment Alerts - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

NewAmsterdam Pharma Co. NV Hits New 52-Week High at $29.66 - Markets Mojo

Oct 04, 2025
pulisher
Oct 03, 2025

Exit strategy if you’re trapped in NewAmsterdam Pharma Company N.V.July 2025 Setups & Verified Technical Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can you recover from losses in NewAmsterdam Pharma Company N.V.Quarterly Performance Summary & Daily Market Momentum Tracking - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How NewAmsterdam Pharma Company N.V. (KH6) stock moves on employment dataJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-02 23:50:02 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using data tools to time your NewAmsterdam Pharma Company N.V. exitEarnings Growth Report & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Why NewAmsterdam Pharma Company N.V. Equity Warrant stock attracts global investorsTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Is NewAmsterdam Pharma Company N.V. stock reversal real or fakeJuly 2025 Trends & Stock Portfolio Risk Management - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - ADVFN

Oct 02, 2025
pulisher
Oct 02, 2025

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - ADVFN

Oct 02, 2025
pulisher
Oct 02, 2025

NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month HighHere's What Happened - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 08:11:23 - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

NewAmsterdam Pharma Stock Hits Day High with 8.41% Surge - Markets Mojo

Sep 30, 2025
pulisher
Sep 30, 2025

NewAmsterdam Pharma Soars 9.15% to Hit Intraday High of $26.75 - Markets Mojo

Sep 30, 2025
pulisher
Sep 30, 2025

What drives NewAmsterdam Pharma Company NV Equity Warrant stock price - earlytimes.in

Sep 30, 2025

Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Newamsterdam Pharma Company Nv Stock (NAMS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kooij Louise Frederika
Chief Accounting Officer
Sep 09 '25
Option Exercise
10.00
150,000
1,500,000
165,000
Kooij Louise Frederika
Chief Accounting Officer
Sep 09 '25
Sale
25.83
150,000
3,874,017
15,000
Topper James N
Director
Sep 08 '25
Buy
24.99
1,260
31,487
3,027,864
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):